Infineon and Blumio expand collaboration to develop radar-based blood pressure sensor

Jun 25, 2020 | Business & Financial Press

Milpitas, CA – June 25, 2020 – Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) announced today that its Silicon Valley Innovation Center (SVIC) has entered a new agreement with Blumio to co-develop a wearable, non-invasive blood pressure sensor based on Infineon’s XENSIV? radar chipset by 2021. The new sensor has the potential to disrupt the USD 45 billion market for wearable cardiovascular monitoring devices by enabling continuous and precise measurement without a cuff.

“Bringing together Infineon’s 60 GHz radar chipset and system understanding with Blumio’s expertise in cardiovascular health monitoring in a more formal engagement lets both companies leverage their strengths to more rapidly bring the product to market,” said Adrian Mikolajczak, Head of the Infineon Silicon Valley Innovation Center, Power and Sensor Systems. “We are excited to see our advanced sensors like radar being applied to novel and rapidly expanding health and wellness applications.”

Upon successful completion, a kit combining Infineon’s radar chipset and development board with Blumio’s software and algorithms would be released to consumer and medical wearable device makers to integrate into their blood pressure monitoring devices.

“We are thrilled to work together with Infineon, the technology leader in radar, to jointly bring the new blood pressure sensor to market,” said Catherine Liao, Co-founder and CEO of Blumio. “We have experienced tremendous support since the beginning of our partnership in 2018 and we look forward to further advance our collaboration with Infineon.”

In its role as an incubator of new technologies, the SVIC will provide funding and resources to support the sensor’s commercialization. The SVIC will leverage Infineon’s engineering, manufacturing, and commercialization expertise, as well as offer office and laboratory space.

“Innovation and partnerships are part of Infineon’s DNA. As an incubator, Infineon works together with startups to develop leading-edge technologies that make life easier, safer and greener,” said Mikolajczak. “The expanded partnership with Blumio truly exemplifies our commitment to invent new technologies that solve problems as we expand our footprint in Silicon Valley.”

The SVIC is Infineon’s incubation facility based in Silicon Valley, California with a mission to foster the region’s startup community and bring new technologies to market. A similar model in Singapore called the Co-Innovation Space offers startups based in Asia Pacific with a yearlong commitment to provide R&D and manufacturing facilities, as well as access to Infineon research, expertise and guidance.

Learn more about Infineon’s startup community: http://www.signoraa.com/cms/en/partner-network/startups/

Founded in 2015, Blumio is a startup based in Silicon Valley with a mission to create sensors and systems to improve people’s health and wellness. The company’s first product is a compact and contactless health sensor that detects and measures blood pressure and pulse continuously without a cuff.

About Infineon

Infineon Technologies AG is a world leader in semiconductor solutions that make life easier, safer and greener. Microelectronics from Infineon is the key to a better future. In the 2019 fiscal year (ending 30 September), the Company reported sales of €8.0 billion with around 41.400 employees worldwide. With the acquisition of US-based Cypress Semiconductor Corporation in April 2020, Infineon has become a global top 10 semiconductor company.

Infineon is listed on the Frankfurt Stock Exchange (ticker symbol: IFX) and in the USA on the over-the-counter market OTCQX International Premier (ticker symbol: IFNNY).

Follow us: Twitter - Facebook - LinkedIn

Information Number

INFPSS202006-074

Press Photos

  • The new sensor has the potential to disrupt the market for wearable cardiovascular monitoring devices by enabling continuous and precise measurement without a cuff.
    The new sensor has the potential to disrupt the market for wearable cardiovascular monitoring devices by enabling continuous and precise measurement without a cuff.
    Blood-pressure-measurement-collaboration-Infineon-Blumio

    JPG | 512 kb | 2126 x 1535 px

  • The new sensor has the potential to disrupt the market for wearable cardiovascular monitoring devices by enabling continuous and precise measurement without a cuff.
    The new sensor has the potential to disrupt the market for wearable cardiovascular monitoring devices by enabling continuous and precise measurement without a cuff.
    BGT60-WFWLB-40-Combi-Compare-to-match

    JPG | 328 kb | 2126 x 1536 px